Industry Insights
-
This Real-World Example Illustrates The Power Of Patient Centricity In Clinical Trials
11/19/2025
Ardelyx Chief Patient Officer Laura Williams, MD, MPH, reflects on how patients with chronic kidney disease (CKD) successfully guided Ardelyx’s clinical trial program.
-
Begin Your AI-Led Digital Clinical Transformation With A Phased Approach
11/18/2025
Discover how to establish a holistic AI-led digital strategy, starting with a top-down, phased approach.
-
7 Patient Recruitment Best Practices Used By Leading Research Studies
11/17/2025
Effective patient recruitment starts with trust. Leading trials build lasting relationships and prioritize respect, simplicity, and community engagement to overcome enrollment challenges.
-
Ease Is How Good Work Happens
11/17/2025
Clinical research teams thrive in the Flow State, where systems align, data connects, and work becomes purposeful, not painful. Ease is clarity, not complexity.
-
The True Cost Of Tool Sprawl
11/17/2025
Tool sprawl in clinical trials creates hidden inefficiencies, fractured collaboration, and delayed insights. Unified systems restore flow, clarity, and control across research teams and functions.
-
De-Risking Schizophrenia Trials: Strategies For Improving Signal Detection
11/17/2025
Here, we summarize a recent webinar on the importance of integrating science-driven decision-making with proactive operational measures to safeguard both trial integrity and investment value in schizophrenia research.
-
Modernizing Vaccine Trials By Leveraging eCOA And Harnessing Innovation
11/17/2025
Explore how integrating eCOA, wearables, and AI-driven technologies can transform your vaccine trials for greater efficiency, patient engagement, and data quality.
-
Early Phase Oncology Site Network: Benefits Of A Personal Touch
11/17/2025
Choose a site network built on partnership — not volume — to drive smoother early-phase oncology trials and deliver better outcomes for sponsors, sites, and patients.
-
The Growing Complexity Of Conducting Oncology Trials
11/17/2025
As diversity plans and multi-regional considerations become core to trial design, early-phase oncology programs must navigate a landscape that offers unprecedented opportunity.
-
Investor Relations, Clinical Operations, And The Future Of Biotech Financing
11/17/2025
Discover how integrating clinical execution with investor strategy can strengthen your position in a tougher capital landscape and accelerate your path to market.